Videx Ec

Generic Name: Videx ec

What is Videx Ec?

Clinical resultsUsing the Videx tablet formulation, the effect of Videx twice daily administration, alone or in combination with zidovudine, was evaluated in several major randomised, controlled clinical trials ACTG 175, ACTG 152, DELTA, CPCRA 007.

The primary demonstration of clinical benefits of didanosine has been made through the ACTG 175 trial with the buffered tablet formulation of Videx administered twice daily.

This study showed that 8 weeks of treatment with zidovudine 200 mg three times daily, Videx tablets 200 mg twice daily, or Videx tablets 200 mg twice daily plus zidovudine 200 mg three times daily decreased mean plasma HIV RNA by 0. In antiretroviral naive patientsThe efficacy of Videx tablet or powder was evaluated in treatment-naive HIV infected patients in two 48-week randomised open label clinical trials.

Through 48 weeks of treatment, results were in favour of the Videx arm. However, no formal conclusion can be drawn on the equivalence of the two regimens. However, no formal conclusions can be drawn on this study due to methodological issues. The efficacy of Videx gastro-resistant capsules was evaluated in treatment-naive HIV infected adults as part of a triple regimen in two 48-week randomised open label clinical trials. Similar log10 plasma HIV RNA decreases from baseline Time Averaged Difference were observed between treatment arms.

At 48 weeks of follow-up, there were similar log10 plasma HIV RNA decreases from baseline Time Averaged Difference between treatment arms. The efficacy of Videx gastro-resistant capsules has not been established in advanced disease or in highly antiretroviral experienced patients.

In the tritherapy setting, the study indicates that, in mostly asymptomatic patients that were stable on their first combination therapy containing Videx twice daily, the shift to a similar combination therapy with Videx once daily did not impact at short term 24 weeks on the existing antiviral efficacy.

Clinical resultsUsing the Videx tablet formulation, the effect of Videx twice daily administration, alone or in combination with zidovudine, was evaluated in several major randomised, controlled clinical trials ACTG 175, ACTG 152, DELTA, CPCRA 007.

The primary demonstration of clinical benefits of didanosine has been made through the ACTG 175 trial with the buffered tablet formulation of Videx administered twice daily. This study showed that 8 weeks of treatment with zidovudine 200 mg three times daily, Videx tablets 200 mg twice daily, or Videx tablets 200 mg twice daily plus zidovudine 200 mg three times daily decreased mean plasma HIV RNA by 0.

In antiretroviral naive patientsThe efficacy of Videx tablet or powder was evaluated in treatment-naive HIV infected patients in two 48-week randomised open label clinical trials. Through 48 weeks of treatment, results were in favour of the Videx arm. However, no formal conclusion can be drawn on the equivalence of the two regimens. However, no formal conclusions can be drawn on this study due to methodological issues.

The efficacy of Videx gastro-resistant capsules was evaluated in treatment-naive HIV infected adults as part of a triple regimen in two 48-week randomised open label clinical trials. Similar log10 plasma HIV RNA decreases from baseline Time Averaged Difference were observed between treatment arms. At 48 weeks of follow-up, there were similar log10 plasma HIV RNA decreases from baseline Time Averaged Difference between treatment arms. The efficacy of Videx gastro-resistant capsules has not been established in advanced disease or in highly antiretroviral experienced patients.

In the tritherapy setting, the study indicates that, in mostly asymptomatic patients that were stable on their first combination therapy containing Videx twice daily, the shift to a similar combination therapy with Videx once daily did not impact at short term 24 weeks on the existing antiviral efficacy.

Therefore, the granules in the Videx gastro-resistant capsules release didanosine into the higher pH of the small intestine. In another study, administration of Videx gastro-resistant capsules 1.

How should I take Videx Ec?

Whenever warranted by clinical conditions, didanosine should be suspended until the diagnosis of pancreatitis is excluded by appropriate laboratory and imaging techniques. Similarly, when treatment with other medicinal products known to cause pancreatic toxicity is required e. If concomitant therapy is unavoidable, there should be close observation. Dose interruption should be considered when biochemical markers of pancreatitis have significantly increased, even in the absence of symptoms.

Significant elevations of triglycerides are a known cause of pancreatitis and warrant close observation.

What should I avoid while taking Videx Ec?

As well, some forms of this medication may not be used for all of the conditions discussed here. If you have not discussed this with your doctor or are not sure why you are taking this medication, speak to your doctor. Do not stop taking this medication without consulting your doctor. Do not give this medication to anyone else, even if they have the same symptoms as you do. It can be harmful for people to take this medication if their doctor has not prescribed it.

Capsules are imprinted with edible ink.

Videx Ec side effects

Even while taking VIDEX EC, you may continue to have HIV-related illnesses, including infections with other disease-producing organisms. Continue to see your healthcare provider regularly and report any medical problems that occur. Tell your healthcare provider about all the medicines you take, including prescription and non-prescription medicines, vitamins and herbal supplements.

VIDEX EC may affect the way other medicines work, and other medicines may affect how VIDEX EC works. Know the medicines you take. Keep a list of your medicines and show it to your healthcare provider and pharmacist when you get a new medicine.

Common Videx Ec ide effects may include:

  • Precautions to prevent transmission should be taken in accordance with national guidelines.

  • Wat u moet doen als u bent vergeten Videx EC in te nemen.

  • Generic Name: didanosine dye-DAN-oh-seen Brand Name: Videx ECVidex EC delayed-release enteric-coated capsules may cause serious and sometimes fatal inflammation of the pancreas pancreatitis.

  • Policies Site Map Contact Us Prominent Web Design.

List Videx EC side effects by likelihood and severity. What should I know regarding pregnancy, nursing and administering Videx EC to children or the elderly.

Interactions See also Warning section. Does Videx EC interact with other medications. Should I avoid certain foods while taking Videx EC.

More about Videx Ec

Consumer resources

Other brands:Buy artane online

Professional resources

Where can I get more information?

  • Before having surgery, tell your doctor or dentist about all the products you use including prescription drugs, nonprescription drugs, and herbal products.

  • Videx EC should be taken with an empty stomach.